Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Systems biology of vascular endothelial growth factors.

Mac Gabhann F, Popel AS.

Microcirculation. 2008 Nov;15(8):715-38. doi: 10.1080/10739680802095964. Review.

2.

Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.

Wu FT, Stefanini MO, Mac Gabhann F, Popel AS.

Methods Enzymol. 2009;467:461-97. doi: 10.1016/S0076-6879(09)67018-X.

3.

Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

Stalmans I.

Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.

PMID:
16334858
4.

Molecular and functional diversity of vascular endothelial growth factors.

Yamazaki Y, Morita T.

Mol Divers. 2006 Nov;10(4):515-27. Review.

PMID:
16972015
5.

Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.

Vajkoczy P, Thurnher A, Hirth KP, Schilling L, Schmiedek P, Ullrich A, Menger MD.

Oncologist. 2000;5 Suppl 1:16-9.

6.

Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling.

Grünewald FS, Prota AE, Giese A, Ballmer-Hofer K.

Biochim Biophys Acta. 2010 Mar;1804(3):567-80. doi: 10.1016/j.bbapap.2009.09.002. Epub 2009 Sep 15. Review.

PMID:
19761875
7.

[Tumor angiogenesis and its inhibitors].

Shibuya M.

Nihon Rinsho. 2012 Nov;70 Suppl 8:149-53. Japanese. No abstract available.

PMID:
23513829
8.

The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease.

Holmes DI, Zachary I.

Genome Biol. 2005;6(2):209. Epub 2005 Feb 1. Review.

9.

The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.

Smith GA, Fearnley GW, Tomlinson DC, Harrison MA, Ponnambalam S.

Biosci Rep. 2015 Aug 18;35(5). pii: e00253. doi: 10.1042/BSR20150171. Review.

10.

Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.

Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.

Princess Takamatsu Symp. 1994;24:162-70. Review.

PMID:
8983073
11.

Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy.

Appelmann I, Liersch R, Kessler T, Mesters RM, Berdel WE.

Recent Results Cancer Res. 2010;180:51-81. doi: 10.1007/978-3-540-78281-0_5. Review.

PMID:
20033378
12.
13.
14.

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1.

Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K.

J Biol Chem. 1999 Jul 23;274(30):21217-22.

15.

VEGF Splicing and the Role of VEGF Splice Variants: From Physiological-Pathological Conditions to Specific Pre-mRNA Splicing.

Guyot M, Pagès G.

Methods Mol Biol. 2015;1332:3-23. doi: 10.1007/978-1-4939-2917-7_1. Review.

PMID:
26285742
16.

Molecular diversity of VEGF-A as a regulator of its biological activity.

Woolard J, Bevan HS, Harper SJ, Bates DO.

Microcirculation. 2009 Oct;16(7):572-92. doi: 10.1080/10739680902997333. Epub 2009 Jun 1. Review.

17.
18.

The biology of vascular endothelial growth factors.

Tammela T, Enholm B, Alitalo K, Paavonen K.

Cardiovasc Res. 2005 Feb 15;65(3):550-63. Review.

PMID:
15664381
19.

The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.

Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ.

Clin Sci (Lond). 2006 May;110(5):575-85.

PMID:
16451124
20.

Vascular endothelial growth factor.

Marti HH.

Adv Exp Med Biol. 2002;513:375-94. Review. No abstract available.

PMID:
12575829

Supplemental Content

Support Center